Authors: Spack, EG Sorgi, FL

Citation: Eg. Spack et Fl. Sorgi, Developing non-viral DNA delivery systems for cancer and infectious disease, DRUG DISC T, 6(4), 2001, pp. 186-197

Authors: Raju, R Spack, EG David, CS

Citation: R. Raju et al., Acetylcholine receptor peptide recognition in HLA DR3-transgenic mice: In vivo responses correlate with MHC-peptide binding, J IMMUNOL, 167(2), 2001, pp. 1118-1124

Authors: Forsthuber, TG Shive, CL Wienhold, W de Graaft, K Spack, EG Sublett, R Melms, A Kort, J Racke, MK Weissert, R

Citation: Tg. Forsthuber et al., T cell epitopes of human myelin oligodendrocyte glycoprotein identified inHLA-DR4 (DRBI0401) transgenic mice are encephalitogenic and are presentedby human B cells, J IMMUNOL, 167(12), 2001, pp. 7119-7125

Authors: Shime, N Sawa, T Fujimoto, J Faure, K Allmond, LR Karaca, T Swanson, BL Spack, EG Wiener-Kronish, JP

Citation: N. Shime et al., Therapeutic administration of anti-PcrV F(ab ')(2) in sepsis associated with Pseudomonas aeruginosa, J IMMUNOL, 167(10), 2001, pp. 5880-5886

Authors: Howard, MC Spack, EG Choudhury, K Greten, TF Schneck, JP

Citation: Mc. Howard et al., MHC-based diagnostics and therapeutics - clinical applications for disease-linked genes, IMMUNOL TOD, 20(4), 1999, pp. 161-165

Authors: Nagvekar, N Corlett, L Jacobson, LW Matsuo, H Chalkley, R Driscoll, PC Deshpande, S Spack, EG Willcox, N

Citation: N. Nagvekar et al., Scanning a DRB30101 (DR52a)-restricted epitope cross-presented by DR3: Overlapping natural and artificial determinants in the human acetylcholine receptor, J IMMUNOL, 162(7), 1999, pp. 4079-4087